«NVIDIA Corp» has announced its plan to invest one billion dollars over 5 years to establish a new laboratory in partnership with «Eli Lilly». This strategic partnership aims to accelerate scientific research and development in the healthcare sector. The companies plan to jointly use advanced artificial intelligence technologies to solve complex medical problems. The new laboratory will become a center of innovation where new methods for disease diagnosis and treatment will be developed. NVIDIA will provide its computing power and AI expertise, while Eli Lilly will bring its pharmaceutical and clinical research knowledge. This collaboration opens up new opportunities for the development of personalized medicine and improving the quality of life for patients worldwide.
